NIH #5UM1TR004906-02
Center for Clinical and Translational Sciences
Active
- Amount
- $5.5M
- Period
- 2024-07-24 → 2031-06-30
- PIs
- 7
- Est. capacity / PI
- ~9 students
Awarded at UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
NIH #1UM1TR004906-01
Center for Clinical and Translational Sciences
Active
- Amount
- $5.7M
- Period
- 2024-07-24 → 2031-06-30
- PIs
- 7
- Est. capacity / PI
- ~9 students
Awarded at UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
NIH #2T32CA009599-35
Training of Academic Surgical Oncologists
Active
- Amount
- $626K
- Period
- 1994-05-25 → 2028-02-29
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA268813-04
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Active
- Amount
- $367K
- Period
- 2022-06-10 → 2027-12-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE
NIH #5U01CA268813-03
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Active
- Amount
- $581K
- Period
- 2022-06-10 → 2027-12-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE
NIH #5R01CA273168-04
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
Active
- Amount
- $581K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
NIH #5R01CA273168-03
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
Active
- Amount
- $552K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
NIH #5R01CA273168-02
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
Active
- Amount
- $568K
- Period
- 2022-07-01 → 2027-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
NIH #5U01CA268813-02
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Active
- Amount
- $593K
- Period
- 2022-06-10 → 2027-05-31
- PIs
- 4
- Est. capacity / PI
- ~0 students
Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE
NIH #1U01CA268813-01
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Active
- Amount
- $449K
- Period
- 2022-06-10 → 2027-05-31
- PIs
- 4
- Est. capacity / PI
- ~0 students
Awarded at METHODIST HOSPITAL RESEARCH INSTITUTE
NIH #5UM1CA186688-09
Texas EXperimental Cancer Therapeutics Network - TEX CTN
Active
- Amount
- $1.7M
- Period
- 2014-03-14 → 2027-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P30CA016672-49
15 Developmental Therapeutics
- Amount
- $25K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #4P30CA016672-48
15 Developmental Therapeutics
- Amount
- $23K
- Period
- 1996-08-28 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5UM1CA186688-08
Texas EXperimental Cancer Therapeutics Network - TEX CTN
- Amount
- $1.7M
- Period
- 2014-03-14 → 2026-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #4UM1CA186688-07
Texas EXperimental Cancer Therapeutics Network - TEX CTN
- Amount
- $2.0M
- Period
- 2014-03-14 → 2026-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P30CA016672-47
15 Developmental Therapeutics
- Amount
- $19K
- Period
- 1996-08-28 → 2024-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA224065-04S2
University of Texas PDX Development and Trial Center
- Amount
- $558K
- Period
- 2017-09-30 → 2023-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA224065-04S1
University of Texas PDX Development and Trial Center
- Amount
- $200K
- Period
- 2022-05-02 → 2023-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U54CA224065-04
Research Project 3: Optimizing DNA damage repair-targeted combination therapy
- Amount
- $218K
- Period
- 2017-09-30 → 2023-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #2UM1CA186688-06
Texas EXperimental Cancer Therapeutics Network - TEX CTN
- Amount
- $5.7M
- Period
- 2014-03-14 → 2023-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-34
Training of Academic Surgical Oncologists
- Amount
- $500K
- Period
- 1994-05-25 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-33
Training of Academic Surgical Oncologists
- Amount
- $604K
- Period
- 1994-05-25 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-32
Training of Academic Surgical Oncologists
- Amount
- $386K
- Period
- 1994-05-25 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-31
Training of Academic Surgical Oncologists
- Amount
- $418K
- Period
- 1994-05-25 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #2T32CA009599-30
Training of Academic Surgical Oncologists
- Amount
- $550K
- Period
- 1994-05-25 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U54CA224065-03
Research Project 3: Optimizing DNA damage repair-targeted combination therapy
- Amount
- $223K
- Period
- 2017-09-30 → 2022-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA224065-03S1
Evaluating drug combinations, efficacy and adaptive feedback in KRAS inhibition
- Amount
- $120K
- Period
- 2017-09-30 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA224065-02S1
University of Texas PDX Development and Trial Center
- Amount
- $60K
- Period
- 2017-09-30 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #4U54CA224065-02
University of Texas PDX Development and Trial Center
- Amount
- $1.4M
- Period
- 2017-09-30 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5UM1CA186688-05
Southwest Early Clinical Trials Consortium
- Amount
- $1.0M
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-05S1
Southwest Early Clinical Trials Consortium
- Amount
- $121K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-05S2
Southwest Early Clinical Trials Consortium
- Amount
- $320K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5UM1CA186688-04
Southwest Early Clinical Trials Consortium
- Amount
- $2.2M
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-03S3
Southwest Early Clinical Trials Consortium
- Amount
- $300K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-03S4
Southwest Early Clinical Trials Consortium
- Amount
- $149K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-03S2
Southwest Early Clinical Trials Consortium
- Amount
- $750K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3UM1CA186688-03S1
Southwest Early Clinical Trials - Phase 2 Consortium
- Amount
- $760K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5UM1CA186688-03
Southwest Early Clinical Trials Consortium
- Amount
- $444K
- Period
- 2014-03-14 → 2020-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA224065-01S1
University of Texas PDX Development and Trial Center
- Amount
- $175K
- Period
- 2017-09-30 → 2019-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-29
Training of Academic Surgical Oncologists
- Amount
- $531K
- Period
- 1994-05-25 → 2018-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #4T32CA009599-28
Training of Academic Surgical Oncologists
- Amount
- $472K
- Period
- 1994-05-25 → 2018-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5T32CA009599-27
Training of Academic Surgical Oncologists
- Amount
- $391K
- Period
- 1994-05-25 → 2016-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #1U54CA224065-01
Research Project 3: Optimizing DNA damage repair-targeted combination therapy
- Amount
- $484K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~8 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR